glp 1 news Jim Cramer dissects how GLP-1 drugs are disrupting the entire healthcare industry A wave of new #GLP1

Associated Press

Current treatments for alcohol and other substance use disorders include behavioral therapy and rehabilitation and a few FDA-approved medications, but the irony is that while these disorders can carry a stigma, so can seeking treatment for them

GLP-1 receptor agonists: The good, the bad, and the ugly: A comprehensive guide for NPs

However, limited or no medical nutrition therapy (MNT) guidelines are provided to healthcare providers and patients regarding adequate nutrient intake during GLP-1RA use

Despite prior authorization protocols, managing this class of medications is becoming increasingly challenging

We have noticed a similar upward trend in utilization and spend for GLP-1s across our book of business, with plan drug spend for Wegovy alone increasing over 500% between 2022 and 2023